Cefixime 50 mg + Clavulanic Acid 31.125 mg/5ml

Cefixime 50 mg + Clavulanic Acid 31.125 mg/5ml is a oral suspension / dry syrup formulated with Cefixime 50 mg + Clavulanic Acid 31.125 mg/5ml. The listed active ingredient profile is Cefixime; Clavulanic Acid, placing the product in the beta-lactam antibiotic + beta-lactamase inhibitor category. The formulation combines a beta-lactam antibacterial with a beta-lactamase inhibitor to help protect antibacterial activity against selected resistance enzymes. The liquid presentation is supplied as an oral suspension/dry-syrup product; reconstitution, shaking, storage and discard instructions must follow the approved label. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.